Worldwide Spending on Cancer Drugs Hits $100 Billion

Global spending on cancer drugs hit $100 billion last year, prompted by new and patented drugs, broader insurance coverage and aging populations. That figure is up more than 10 percent since 2013.

Global spending on cancer drugs hit $100 billion last year, prompted by new and patented drugs, broader insurance coverage and aging populations. That figure is up slightly more than 10 percent since 2013. (Modern Healthcare)